APSARD and Tris Pharma Announce the 2021 Tris Research Award in ADHD
APSARD and Tris Pharma Announce the 2021 Tris Research Award in ADHD News provided by Share this article Share this article MONMOUTH JUNCTION, N.J., Jan. 28, 2021 /PRNewswire/ -- The American Professional Society of ADHD and Related Disorders ("APSARD"), a professional organization focused on improving outcomes for individuals with ADHD and their families, and Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of approved products for the treatment of Attenti...
United States Deirdre Mccarthy Enrique Carrazana Deirdrem Mccarthy Angeli Canekeratne Joseph Biederman
Source: prnewswire.com